Rafarma Pharmaceuticals Inc. - ESG Rating & Company Profile powered by AI
This analysis of Rafarma Pharmaceuticals Inc. is prepared by All Street Sevva using advanced AI. The Disclosure score includes seventeen UN SDGs including: 'Affordable & Clean Energy', 'Reduced Inequalities' and 'Life on Land'. This analysis of Rafarma Pharmaceuticals Inc. incorporates data from across the web and also from available documents by Rafarma Pharmaceuticals Inc..
Rafarma Pharmaceuticals Inc. in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Rafarma Pharmaceuticals Inc. | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Rafarma Pharmaceuticals Inc. have an accelerator or VC vehicle to help deliver innovation?
Does Rafarma Pharmaceuticals Inc. disclose current and historical energy intensity?
Does Rafarma Pharmaceuticals Inc. report the average age of the workforce?
Does Rafarma Pharmaceuticals Inc. reference operational or capital allocation in relation to climate change?
Does Rafarma Pharmaceuticals Inc. disclose its ethnicity pay gap?
Does Rafarma Pharmaceuticals Inc. disclose cybersecurity risks?
Does Rafarma Pharmaceuticals Inc. offer flexible work?
Does Rafarma Pharmaceuticals Inc. have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Rafarma Pharmaceuticals Inc. disclose the number of employees in R&D functions?
Does Rafarma Pharmaceuticals Inc. conduct supply chain audits?
Does Rafarma Pharmaceuticals Inc. disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Rafarma Pharmaceuticals Inc. conduct 360 degree staff reviews?
Does Rafarma Pharmaceuticals Inc. disclose the individual responsible for D&I?
Does Rafarma Pharmaceuticals Inc. disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Rafarma Pharmaceuticals Inc. disclose current and / or historical scope 2 emissions?
Does Rafarma Pharmaceuticals Inc. disclose water use targets?
Does Rafarma Pharmaceuticals Inc. have careers partnerships with academic institutions?
Did Rafarma Pharmaceuticals Inc. have a product recall in the last two years?
Does Rafarma Pharmaceuticals Inc. disclose incidents of discrimination?
Does Rafarma Pharmaceuticals Inc. allow for Work Councils/Collective Agreements to be formed?
Has Rafarma Pharmaceuticals Inc. issued a profit warning in the past 24 months?
Does Rafarma Pharmaceuticals Inc. disclose parental leave metrics?
Does Rafarma Pharmaceuticals Inc. disclose climate scenario or pathway analysis?
Does Rafarma Pharmaceuticals Inc. disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Rafarma Pharmaceuticals Inc. disclose the pay ratio of women to men?
Does Rafarma Pharmaceuticals Inc. support suppliers with sustainability related research and development?
Does Rafarma Pharmaceuticals Inc. disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Rafarma Pharmaceuticals Inc. reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Rafarma Pharmaceuticals Inc. involved in embryonic stem cell research?
Does Rafarma Pharmaceuticals Inc. disclose GHG and Air Emissions intensity?
Does Rafarma Pharmaceuticals Inc. disclose its waste policy?
Does Rafarma Pharmaceuticals Inc. report according to TCFD requirements?
Does Rafarma Pharmaceuticals Inc. disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Rafarma Pharmaceuticals Inc. disclose energy use targets?
Does Rafarma Pharmaceuticals Inc. disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Rafarma Pharmaceuticals Inc. have a policy relating to cyber security?
Have a different question?
Potential Risks for Rafarma Pharmaceuticals Inc.
These potential risks are based on the size, segment and geographies of the company.
Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture the first medical cannabis suppositories for patients suffering from inflammatory bowel disease. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company is based in Sandy, Utah with a manufacturing and distribution facility in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.